Transition Therapeutics Inc (TTHI.OQ) Analyst Research| Reuters.com
Edition:
United States

Transition Therapeutics Inc (TTHI.OQ)

TTHI.OQ on NASDAQ Stock Exchange Global Market

0.70USD
28 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.70
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,211
52-wk High
$2.74
52-wk Low
$0.73

Name Age Since Current Position

Tony Cruz

1999 Chairman of the Board, Chief Executive Officer

Carl Damiani

40 2015 President, Chief Operating Officer

Nicole Rusaw

39 2011 Chief Financial Officer

Bruce Connop

43 2012 Vice President - Non-Clinical & Pharmaceutical Development

Aleksandra Pastrak

46 2011 Vice President - Clinical Development and Medical Officer